Published: May, 2018
The global cell expansion market depicts a highly consolidated structure to exist in its vendor landscape, owing to the presence of a handful of players, says Transparency Market Research based on a recently published report. Leading players in the market are increasing the rate of investments, thereby cementing their position in the global cell expansion market. The companies are also carrying out extensive research-based activities to develop advanced cell expansion applications. In the next few years, most companies are expected to shift their focus to achieve product differentiation. Presence of a variety of services along with new players regularly making their foray in the market is expected to intensify the competition during the next few years.
Takara Bio, Inc., Corning Incorporated, GE Healthcare, Terumo Corporation, Octane Biotech, Inc., Lonza Group, Danaher Corporation (Pall Corporation), Eppendorf AG, PeproTech, Inc., Becton, Dickinson and Company, STEMCELL Technologies, Merck Millipore (Merck KGaA), Bio-Techne (R&D Systems), Cell Signaling Technology, Inc., Thermo Fisher Scientific, Inc., and HiMedia Laboratories, and CellGenix GmbH, are key players operating in the global cell expansion market.
The global cell expansion market is expected to grow at a stellar CAGR of 14.70% during the forecast period from 2016 to 2024. The market initially had gained a revenue worth US$7.7 bn in 2015, which is further expected to increase up to US$26 bn by 2024.
Rising Preference for Regenerative Medicines Boosts Market’s Growth
The global cell expansion market is gaining extensive growth mainly due to widespread prevalence of chronic medical conditions, which further increasing the need for use of cell expansion-based processes. The preference for regenerative medicines is also fast rising, which is greatly expected to propel the global cell expansion market’s growth in the near future. As newer cell-based therapies are introduced, the number of patients who want to utilize the treatments increases, consequently making the market gain extensive growth. Lastly, a rise in biopharmaceuticals is another factor, which is likely to augur the global cell expansion market to expand substantially during the upcoming years.
Lack of Skilled Workforce in Underdeveloped Regions Dampens Growth
High cost of cell expansion operations could discourage those having less disposable income to not opt for treatments that incorporate cell expansion-based processes, thereby restraining the market. This could highly occur in several economies mainly located in developing and underdeveloped regions of Asia Pacific and Latin America. Lack of skilled workforce and high-tech instrumentation in these regions is also known to substantially restrict the global cell expansion market. Nevertheless, a rising awareness about the existence of cell-expansion processes is increasing interest levels shown by players to grow in the market. This awareness can ultimately contribute towards early diagnosis of several chronic diseases, consequently offsetting the restraints during the upcoming years.
The review is based on a report by Transparency Market Research (TMR), titled “Cell Expansion Market (Cell Type - Human Stem Cells, Human Differentiated Cells, and Animal Cells; Product - Instruments, Consumables, and Disposables; End User - Hospitals, CMO & CRO, Biotechnology & Pharmaceutical Companies, and Academic & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016–2024.”
- Presence of a variety of services along with new players regularly making their foray in the market is expected to intensify the competition during the next few years.
- The preference for regenerative medicines is also fast rising, which is greatly expected to propel the global cell expansion market’s growth in the near future.
The global cell expansion market is segmented into:
By Type of Cells
- Human Cells
- Stem Cells
- Adult Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Stem Cells
- Differentiated Cells
- Animal Cells
By Product Type
- Cell Expansion Supporting Equipment
- Automated Cell Expansion
- Bioreactor Accessories
- Tissue Culture Flasks
By End User
- CMO & CRO
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- GCC Countries
- Rest of Middle East & Africa
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453